List of Tables
Table 1. Cystic Fibrosis Therapeutics Market Trends
Table 2. Cystic Fibrosis Therapeutics Market Drivers & Opportunity
Table 3. Cystic Fibrosis Therapeutics Market Challenges
Table 4. Cystic Fibrosis Therapeutics Market Restraints
Table 5. Global Cystic Fibrosis Therapeutics Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Cystic Fibrosis Therapeutics Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Cystic Fibrosis Therapeutics Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Cystic Fibrosis Therapeutics Product Type
Table 9. Key Companies Time to Begin Mass Production of Cystic Fibrosis Therapeutics
Table 10. Global Cystic Fibrosis Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cystic Fibrosis Therapeutics as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Cystic Fibrosis Therapeutics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Cystic Fibrosis Therapeutics Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Cystic Fibrosis Therapeutics Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Cystic Fibrosis Therapeutics Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Cystic Fibrosis Therapeutics Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Cystic Fibrosis Therapeutics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Cystic Fibrosis Therapeutics Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Cystic Fibrosis Therapeutics Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Cystic Fibrosis Therapeutics Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Cystic Fibrosis Therapeutics Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Cystic Fibrosis Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Cystic Fibrosis Therapeutics Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Cystic Fibrosis Therapeutics Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Cystic Fibrosis Therapeutics Sales Value by Region (2019-2024) & (%)
Table 27. Global Cystic Fibrosis Therapeutics Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Cystic Fibrosis Therapeutics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Cystic Fibrosis Therapeutics Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Cystic Fibrosis Therapeutics Sales Value, (2025-2030) & (US$ Million)
Table 31. Vertex Pharmaceuticals Basic Information List
Table 32. Vertex Pharmaceuticals Description and Business Overview
Table 33. Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Products, Services and Solutions
Table 34. Revenue (US$ Million) in Cystic Fibrosis Therapeutics Business of Vertex Pharmaceuticals (2019-2024)
Table 35. Vertex Pharmaceuticals Recent Developments
Table 36. F. Hoffmann-La Roche Basic Information List
Table 37. F. Hoffmann-La Roche Description and Business Overview
Table 38. F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Products, Services and Solutions
Table 39. Revenue (US$ Million) in Cystic Fibrosis Therapeutics Business of F. Hoffmann-La Roche (2019-2024)
Table 40. F. Hoffmann-La Roche Recent Developments
Table 41. AbbVie Basic Information List
Table 42. AbbVie Description and Business Overview
Table 43. AbbVie Cystic Fibrosis Therapeutics Products, Services and Solutions
Table 44. Revenue (US$ Million) in Cystic Fibrosis Therapeutics Business of AbbVie (2019-2024)
Table 45. AbbVie Recent Developments
Table 46. Gilead Sciences Basic Information List
Table 47. Gilead Sciences Description and Business Overview
Table 48. Gilead Sciences Cystic Fibrosis Therapeutics Products, Services and Solutions
Table 49. Revenue (US$ Million) in Cystic Fibrosis Therapeutics Business of Gilead Sciences (2019-2024)
Table 50. Gilead Sciences Recent Developments
Table 51. Novartis Basic Information List
Table 52. Novartis Description and Business Overview
Table 53. Novartis Cystic Fibrosis Therapeutics Products, Services and Solutions
Table 54. Revenue (US$ Million) in Cystic Fibrosis Therapeutics Business of Novartis (2019-2024)
Table 55. Novartis Recent Developments
Table 56. AstraZeneca Basic Information List
Table 57. AstraZeneca Description and Business Overview
Table 58. AstraZeneca Cystic Fibrosis Therapeutics Products, Services and Solutions
Table 59. Revenue (US$ Million) in Cystic Fibrosis Therapeutics Business of AstraZeneca (2019-2024)
Table 60. AstraZeneca Recent Developments
Table 61. Bayer Basic Information List
Table 62. Bayer Description and Business Overview
Table 63. Bayer Cystic Fibrosis Therapeutics Products, Services and Solutions
Table 64. Revenue (US$ Million) in Cystic Fibrosis Therapeutics Business of Bayer (2019-2024)
Table 65. Bayer Recent Developments
Table 66. Celtaxsys Basic Information List
Table 67. Celtaxsys Description and Business Overview
Table 68. Celtaxsys Cystic Fibrosis Therapeutics Products, Services and Solutions
Table 69. Revenue (US$ Million) in Cystic Fibrosis Therapeutics Business of Celtaxsys (2019-2024)
Table 70. Celtaxsys Recent Developments
Table 71. Pharmaxis Basic Information List
Table 72. Pharmaxis Description and Business Overview
Table 73. Pharmaxis Cystic Fibrosis Therapeutics Products, Services and Solutions
Table 74. Revenue (US$ Million) in Cystic Fibrosis Therapeutics Business of Pharmaxis (2019-2024)
Table 75. Pharmaxis Recent Developments
Table 76. ProQR Therapeutics Basic Information List
Table 77. ProQR Therapeutics Description and Business Overview
Table 78. ProQR Therapeutics Cystic Fibrosis Therapeutics Products, Services and Solutions
Table 79. Revenue (US$ Million) in Cystic Fibrosis Therapeutics Business of ProQR Therapeutics (2019-2024)
Table 80. ProQR Therapeutics Recent Developments
Table 81. PTC Therapeutics Basic Information List
Table 82. PTC Therapeutics Description and Business Overview
Table 83. PTC Therapeutics Cystic Fibrosis Therapeutics Products, Services and Solutions
Table 84. Revenue (US$ Million) in Cystic Fibrosis Therapeutics Business of PTC Therapeutics (2019-2024)
Table 85. PTC Therapeutics Recent Developments
Table 86. Alcresta Therapeutics Basic Information List
Table 87. Alcresta Therapeutics Description and Business Overview
Table 88. Alcresta Therapeutics Cystic Fibrosis Therapeutics Products, Services and Solutions
Table 89. Revenue (US$ Million) in Cystic Fibrosis Therapeutics Business of Alcresta Therapeutics (2019-2024)
Table 90. Alcresta Therapeutics Recent Developments
Table 91. Insmed Incorporated Basic Information List
Table 92. Insmed Incorporated Description and Business Overview
Table 93. Insmed Incorporated Cystic Fibrosis Therapeutics Products, Services and Solutions
Table 94. Revenue (US$ Million) in Cystic Fibrosis Therapeutics Business of Insmed Incorporated (2019-2024)
Table 95. Insmed Incorporated Recent Developments
Table 96. Savara Basic Information List
Table 97. Savara Description and Business Overview
Table 98. Savara Cystic Fibrosis Therapeutics Products, Services and Solutions
Table 99. Revenue (US$ Million) in Cystic Fibrosis Therapeutics Business of Savara (2019-2024)
Table 100. Savara Recent Developments
Table 101. Cyclacel Pharmaceuticals Basic Information List
Table 102. Cyclacel Pharmaceuticals Description and Business Overview
Table 103. Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Products, Services and Solutions
Table 104. Revenue (US$ Million) in Cystic Fibrosis Therapeutics Business of Cyclacel Pharmaceuticals (2019-2024)
Table 105. Cyclacel Pharmaceuticals Recent Developments
Table 106. Vectura Basic Information List
Table 107. Vectura Description and Business Overview
Table 108. Vectura Cystic Fibrosis Therapeutics Products, Services and Solutions
Table 109. Revenue (US$ Million) in Cystic Fibrosis Therapeutics Business of Vectura (2019-2024)
Table 110. Vectura Recent Developments
Table 111. Allergan Basic Information List
Table 112. Allergan Description and Business Overview
Table 113. Allergan Cystic Fibrosis Therapeutics Products, Services and Solutions
Table 114. Revenue (US$ Million) in Cystic Fibrosis Therapeutics Business of Allergan (2019-2024)
Table 115. Allergan Recent Developments
Table 116. Key Raw Materials Lists
Table 117. Raw Materials Key Suppliers Lists
Table 118. Cystic Fibrosis Therapeutics Downstream Customers
Table 119. Cystic Fibrosis Therapeutics Distributors List
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
Table 123. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Cystic Fibrosis Therapeutics Product Picture
Figure 2. Global Cystic Fibrosis Therapeutics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Cystic Fibrosis Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 4. Cystic Fibrosis Therapeutics Report Years Considered
Figure 5. Global Cystic Fibrosis Therapeutics Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Cystic Fibrosis Therapeutics Revenue in 2023
Figure 7. Cystic Fibrosis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. CFTR Picture
Figure 9. Mucolytics Picture
Figure 10. PERT Picture
Figure 11. Anti-infectives Picture
Figure 12. Bronchodilators Picture
Figure 13. Global Cystic Fibrosis Therapeutics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Cystic Fibrosis Therapeutics Sales Value Market Share by Type, 2023 & 2030
Figure 15. Product Picture of Hospitals
Figure 16. Product Picture of Clinics
Figure 17. Global Cystic Fibrosis Therapeutics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Cystic Fibrosis Therapeutics Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Cystic Fibrosis Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Cystic Fibrosis Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Cystic Fibrosis Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Cystic Fibrosis Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Cystic Fibrosis Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Cystic Fibrosis Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Cystic Fibrosis Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Cystic Fibrosis Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Cystic Fibrosis Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Cystic Fibrosis Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Cystic Fibrosis Therapeutics Sales Value (%), (2019-2030)
Figure 30. United States Cystic Fibrosis Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Cystic Fibrosis Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Cystic Fibrosis Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Cystic Fibrosis Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Cystic Fibrosis Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Cystic Fibrosis Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 36. China Cystic Fibrosis Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Cystic Fibrosis Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 38. China Cystic Fibrosis Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Cystic Fibrosis Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Cystic Fibrosis Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Cystic Fibrosis Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Cystic Fibrosis Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Cystic Fibrosis Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Cystic Fibrosis Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Cystic Fibrosis Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Cystic Fibrosis Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Cystic Fibrosis Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 48. India Cystic Fibrosis Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Cystic Fibrosis Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 50. India Cystic Fibrosis Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 51. Cystic Fibrosis Therapeutics Industrial Chain
Figure 52. Cystic Fibrosis Therapeutics Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
